Related Experiment Video
Updated: May 16, 2026

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Bone-specific overexpression of NPY modulates osteogenesis
I Matic1, B G Matthews, T Kizivat
1Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT 06032, USA.
Objectives:
Neuropeptide Y (NPY) is a peptide involved in the regulation of appetite and energy homeostasis. Genetic data indicates that NPY decreases bone formation via central and peripheral activities. NPY is produced by various cell types including osteocytes and osteoblasts and there is evidence suggesting that peripheral NPY is important for regulation of bone formation. We sought to investigate the role of bone-derived NPY in bone metabolism.
Methods:
We generated a mouse where NPY was over-expressed specifically in mature osteoblasts and osteocytes (Col2.3NPY) and characterized the bone phenotype of these mice in vivo and in vitro.
Results:
Trabecular and cortical bone volume was reduced in 3-month-old animals, however bone formation rate and osteoclast activity were not significantly changed. Calvarial osteoblast cultures from Col2.3NPY mice also showed reduced mineralization and expression of osteogenic marker genes.
Conclusions:
Our data suggest that osteoblast/osteocyte-derived NPY is capable of altering osteogenesis in vivo and in vitro and may represent an important source of NPY for regulation of bone formation. However, it is possible that other peripheral sources of NPY such as the sympathetic nervous system and vasculature also contribute to peripheral regulation of bone turnover.
Insights
Bone-derived Neuropeptide Y (NPY) reduces bone formation. Overexpressing NPY in osteoblasts and osteocytes decreased bone volume and impaired osteogenic gene expression in mice, highlighting NPY
Area of Science:
- Endocrinology
- Bone Biology
- Metabolic Regulation
Background:
- Neuropeptide Y (NPY) is implicated in appetite and energy balance.
- Genetic evidence suggests NPY negatively impacts bone formation centrally and peripherally.
- NPY is produced by bone cells, including osteocytes and osteoblasts, suggesting a role in bone metabolism.
Purpose of the Study:
- To investigate the specific role of NPY derived from bone cells in regulating bone metabolism.
- To determine if osteoblast/osteocyte-derived NPY influences osteogenesis.
Main Methods:
- Generation of a transgenic mouse model (Col2.3NPY) with NPY overexpression in mature osteoblasts and osteocytes.
- In vivo characterization of bone phenotype in Col2.3NPY mice.
- In vitro analysis of calvarial osteoblast cultures from Col2.3NPY mice.
Main Results:
- Col2.3NPY mice exhibited reduced trabecular and cortical bone volume at 3 months.
- Bone formation rate and osteoclast activity remained unchanged.
- Osteoblast cultures showed decreased mineralization and reduced expression of osteogenic markers.
Conclusions:
- Osteoblast/osteocyte-derived NPY can alter osteogenesis both in vivo and in vitro.
- Bone-derived NPY is a significant factor in regulating bone formation.
- Other peripheral NPY sources, like the sympathetic nervous system and vasculature, may also contribute to bone turnover.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Bone Remodeling and Repair
The Nucleolus
Bone Remodeling
